Differences and similarities between disseminated intravascular coagulation and thrombotic microangiopathy
- PMID: 30008620
- PMCID: PMC6040080
- DOI: 10.1186/s12959-018-0168-2
Differences and similarities between disseminated intravascular coagulation and thrombotic microangiopathy
Abstract
Introduction: Both disseminated intravascular coagulation (DIC) and thrombotic microangiopathy (TMA) cause microvascular thrombosis associated with thrombocytopenia, bleeding tendency and organ failure.
Reports and discussion: The frequency of DIC is higher than that of thrombotic thrombocytopenic purpura (TTP). Many patients with TMA are diagnosed with DIC, but only about 15% of DIC patients are diagnosed with TMA. Hyperfibrinolysis is observed in most patients with DIC, and microangiopathic hemolytic anemia is observed in most patients with TMA. Markedly decreased ADAMTS13 activity, the presence of Shiga-toxin-producing Escherichia coli (STEC) and abnormality of the complement system are useful for the diagnosis of TTP, STEC-hemolytic uremic syndrome (HUS)and atypical HUS, respectively. However, there are no specific biomarkers for the diagnosis of DIC.
Conclusion: Although DIC and TMA are similar appearances, all coagulation, fibrinolysis and platelet systems are activated in DIC, and only platelets are markedly activated in TMA.
Keywords: DIC; Hyperfibrinolysis; Microangiopathic hemolytic anemia; Microvascular thrombosis; Organ failure; TMA.
Conflict of interest statement
The study protocol was approved by the Human Ethics Review Committee of the Mie University School of Medicine, and a signed consent form was obtained from each subject. This study was faithfully carried out in accordance with the principles of the Declaration of Helsinki.A signed consent form was obtained from each subject.The authors declare that they have no competing interests.Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
Similar articles
-
Practical approach to thrombocytopenia in patients with sepsis: a narrative review.Thromb J. 2024 Jul 22;22(1):67. doi: 10.1186/s12959-024-00637-0. Thromb J. 2024. PMID: 39039520 Free PMC article. Review.
-
HUS and TTP: traversing the disease and the age spectrum.Semin Nephrol. 2023 Jul;43(4):151436. doi: 10.1016/j.semnephrol.2023.151436. Epub 2023 Nov 10. Semin Nephrol. 2023. PMID: 37949684 Review.
-
Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis.Clin Adv Hematol Oncol. 2016 Nov;14 Suppl 11(11):2-15. Clin Adv Hematol Oncol. 2016. PMID: 27930620 Review.
-
Gastrointestinal infection-related disseminated intravascular coagulation mimicking Shiga toxin-mediated hemolytic uremic syndrome - implications of classical clinical indexes in making the diagnosis: A case report and literature review.World J Clin Cases. 2019 Jul 6;7(13):1660-1670. doi: 10.12998/wjcc.v7.i13.1660. World J Clin Cases. 2019. PMID: 31367625 Free PMC article.
-
Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?Hypertens Res. 2005 Jan;28(1):89-95. doi: 10.1291/hypres.28.89. Hypertens Res. 2005. PMID: 15969259
Cited by
-
Autoimmune Hemolytic Anemia following Septic Shock with Escherichia Coli; a Case Report.Arch Acad Emerg Med. 2023 Nov 6;12(1):e5. doi: 10.22037/aaem.v12i1.2104. eCollection 2024. Arch Acad Emerg Med. 2023. PMID: 38022718 Free PMC article.
-
Assessment of global coagulation function under treatment with emicizumab concomitantly with bypassing agents in haemophilia A with inhibitor (UNEBI Study): multicentre open-label non-randomised clinical trial.BMJ Open. 2022 Feb 17;12(2):e056922. doi: 10.1136/bmjopen-2021-056922. BMJ Open. 2022. PMID: 35177463 Free PMC article. Clinical Trial.
-
Predictors of very early death in acute promyelocytic leukemia: a retrospective real-world cohort study.Ann Hematol. 2023 Nov;102(11):3031-3037. doi: 10.1007/s00277-023-05422-z. Epub 2023 Aug 31. Ann Hematol. 2023. PMID: 37650885 Free PMC article.
-
Soluble C-Type Lectin-Like Receptor 2 Is a Biomarker for Disseminated Intravascular Coagulation.J Clin Med. 2021 Jun 28;10(13):2860. doi: 10.3390/jcm10132860. J Clin Med. 2021. PMID: 34203210 Free PMC article.
-
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020).J Intensive Care. 2021 Aug 25;9(1):53. doi: 10.1186/s40560-021-00555-7. J Intensive Care. 2021. PMID: 34433491 Free PMC article.
References
-
- Taylor FB, Jr, Toh CH, Hoots WK, Wada H, Levi M. Scientific subcommittee on disseminated intravascular coagulation (DIC) of the international society on thrombosis and Haemostasis (ISTH): towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86:1327–1330. doi: 10.1055/s-0037-1616068. - DOI - PubMed
-
- Matsumoto M, Fujimura Y, Wada H, Kokame K, Miyakawa Y, Ueda Y, Higasa S, Moriki T, Yagi H, Miyata T, Murata M. For TTP group of blood coagulation abnormalities research team, research on rare and intractable disease supported by health, labour, and welfare sciences research grants.: Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) 2017 in Japan. Int J Hematol. 2017;106:3–15. doi: 10.1007/s12185-017-2264-7. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources